4 ms·
There is already a lot of competition here (which is not necessarily a bad thing)...will be interested to see how 20n can differentiate and or add value upon wh
by red_dazzler 12y ago
There is already a lot of competition here (which is not necessarily a bad thing)...will be interested to see how 20n can differentiate and or add value upon what already exists.
http://www.nature.com/nrmicro/journal/v10/n3/fig_tab/nrmicro2717_T1.html http://www.nature.com/nrmicro/journal/v10/n3/fig_tab/nrmicro...
http://www.ncbi.nlm.nih.gov/pubmed/25080239 http://www.ncbi.nlm.nih.gov/pubmed/25080239
http://www.biomedcentral.com/1752-0509/5/122 http://www.biomedcentral.com/1752-0509/5/122
http://www.ncbi.nlm.nih.gov/pubmed/24642060 http://www.ncbi.nlm.nih.gov/pubmed/24642060
- saurabh20n 12y agoIndeed! We love this community [1]. We started 20n with DARPA's help, in part to gather more steam around the accuracy of software predictions tools within synthetic biology. You seem to have worked on these tools, and so must know the pain of convincing wet-lab scientists to follow up on the sw predictions. Paracetamol, both for academics and to pharma, was a non-biosynthesizable molecule. But once we had the prediction, we were able to go to the lab to construct the microbe pretty easily. In the end, the tool is the start of the process. We are investing significant resources in constructing the microbes. Over the coarse of the next two year, hopefully you will find some novel molecules in the ones we move to bioproduction. [1] Have to! We are part of it. :) We know most of them, and they probably know us.